Outcome of postoperative radiation therapy for cholangiocarcinoma and analysis of dose-volume histogram of remnant liver-Reference-Cited by-同舟云学术

Outcome of postoperative radiation therapy for cholangiocarcinoma and analysis of dose-volume histogram of remnant liver

Published:2019-08 Issue:31 Volume:98 Page:e16673
ISSN:0025-7974
Container-title:Medicine
language:en
Short-container-title:

Author:

Mukai Yuki,Matsuyama Ryusei,Koike Izumi,Kumamoto Takafumi,Kaizu Hisashi,Homma Yuki,Takano Shoko,Sawada Yu,Sugiura Madoka,Yabushita Yasuhiro,Ito Eiko,Sato Mizuki,Endo Itaru,Hata Masaharu

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference34 articles.

1. Recent advances in the management of cholangiocarcinomas;Vauthey;Semin Liver Dis,1994

2. Defining the role of adjuvant therapy: cholangiocarcinoma and gall bladder cancer;Williams;Semin Radiat Oncol,2014

3. Impact of classification of hilar cholangiocarcinomas (Klatskin tumors) on the incidence of intra- and extrahepatic cholangiocarcinoma in the United States;Welzel;J Natl Cancer Inst,2006

4. Adjuvant chemotherapy and radiation therapy is associated with improved survival for patients with extrahepatic cholangiocarcinoma;Hoehn;Ann Surg Oncol,2015

5. Chemoradiation and brachytherapy in extrahepatic bile duct carcinoma;Mattiucci;Crit Rev Oncol Hematol,2014

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Current Role of Radiation in the Management of Cholangiocarcinoma—A Narrative Review;Cancers;2024-05-04

2. LGR5+ Intestinal Stem Cells Display Sex-Dependent Radiosensitivity;Cells;2023-12-25

3. LGR5+ Intestinal Stem Cells Display Sex Dependent Radiosensitivity;2023-12-07

4. Differentiation of giant cell tumours of bone, primary aneurysmal bone cysts, and aneurysmal bone cysts secondary to giant cell tumour of bone: using whole-tumour CT texture analysis parameters as quantitative biomarkers;Clinical Radiology;2023-07

5. American Radium Society (ARS) Appropriate Use Criteria (AUC) for Extrahepatic Cholangiocarcinoma;American Journal of Clinical Oncology;2022-12-19